Skip to main content

Moderna, Inc.

MRNA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001682852

In the last 90 days, Moderna, Inc. insiders filed 0 open-market purchases and 5 sales; 784 institutions reported holding it in 13F filings for Q2 2026, worth $22.3B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Moderna, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
5 filings
4 insiders, $49.2M in total
Insiders trading
4
Net value
−$49.2M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Moderna, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Moderna, Inc.
NameTitleLast reported holdingLast filingFilings, past year
Hoge StephenPresident1,562,029Sep 16, 202613
Mock James MChief Financial Officer59,375Sep 14, 202616
Klinger Shannon ThymeChief Legal Officer81,340Sep 8, 202612
Bancel StephaneChief Executive Officer6,440,260Aug 7, 20264
McDonnell Michael RDirector–Jul 10, 20261
Banque Soria EsterChief Commercial Officer–Jul 7, 20261
Afeyan NoubarDirector3,924IndirectMay 22, 20263
Tallett Elizabeth EDirector4,761May 8, 20262
Nader FrancoisDirector32,781May 8, 20262
Rubenstein David M.Director9,643May 8, 20262
Nabel Elizabeth GDirector19,317May 8, 20262
Horning SandraDirector18,585May 8, 20262
Hussain AbbasDirector12,066May 8, 20264
Sagan PaulDirector312,027IndirectMay 1, 20250
Langer RobertDirector11,467,664May 7, 20240
Berenson StephenDirector22,203May 7, 20240
Garay ArpaChief Commercial Officer3,690Dec 7, 20230
Andres JuanSee remarks12,803Dec 30, 20220
Burton PaulChief Medical Officer954Nov 8, 20220
Meline David WChief Financial Officer2,857Aug 11, 20220
Zaks Tal ZviChief Medical Officer0Jul 2, 20210

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 12, 2022 (view filing)Aug 111 dayBancel StephaneChief Executive OfficerSSale−10.0K$174.23−$1.74M−0.1%6.76M after
Aug 12, 2022 (view filing)Aug 102 daysAfeyan NoubarDirectorSSale−10.0K$174.09−$1.74M−0.4%2.46M after
Aug 11, 2022 (view filing)Aug 101 dayHoge StephenPresidentSSale−244$173.66−$42.4K0.0%1.62M after
Aug 11, 2022 (view filing)Aug 101 dayAndres JuanSee remarksSSale−2.20K$174.05−$383.6K−17.2%10.6K after2 lots
Aug 11, 2022 (view filing)Aug 101 dayMeline David WChief Financial OfficerSSale−164$173.66−$28.5K−5.4%2.86K after
Aug 9, 2022 (view filing)Aug 81 dayBurton PaulChief Medical OfficerSSale−865$185.10−$160.1K−53.8%744 after
Aug 5, 2022 (view filing)Aug 3-42 daysBancel StephaneChief Executive OfficerSSale−80.0K$189.87−$15.2M−1.5%5.41M after12 lots
Aug 5, 2022 (view filing)Aug 41 dayBancel StephaneChief Executive OfficerSSale−10.0K$185.75−$1.86M−0.1%6.77M after
Aug 5, 2022 (view filing)Aug 32 daysAndres JuanSee remarksSSale−2.00K$167.99−$336.0K−16.2%10.4K after
Aug 5, 2022 (view filing)Aug 32 daysAfeyan NoubarDirectorSSale−10.0K$167.99−$1.68M−0.4%2.47M after
Jul 29, 2022 (view filing)Jul 272 daysAndres JuanSee remarksSSale−2.00K$161.00−$322.0K−16.2%10.4K after
Jul 29, 2022 (view filing)Jul 27-282 daysBancel StephaneChief Executive OfficerSSale−80.0K$156.53−$12.5M−1.5%5.41M after12 lots
Jul 29, 2022 (view filing)Jul 281 dayBancel StephaneChief Executive OfficerSSale−10.0K$157.00−$1.57M−0.1%6.78M after
Jul 29, 2022 (view filing)Jul 272 daysAfeyan NoubarDirectorSSale−10.0K$161.00−$1.61M−0.4%2.48M after
Jul 26, 2022 (view filing)Jul 251 dayHoge StephenPresidentSSale−10.0K$162.75−$1.63M−0.6%1.62M after
Jul 22, 2022 (view filing)Jul 20-212 daysBancel StephaneChief Executive OfficerSSale−80.0K$167.51−$13.4M−1.5%5.41M after12 lots
Jul 22, 2022 (view filing)Jul 211 dayBancel StephaneChief Executive OfficerSSale−10.0K$165.36−$1.65M−0.1%6.79M after
Jul 22, 2022 (view filing)Jul 202 daysAndres JuanSee remarksSSale−2.00K$167.00−$334.0K−16.2%10.4K after
Jul 22, 2022 (view filing)Jul 202 daysAfeyan NoubarDirectorSSale−10.0K$167.00−$1.67M−0.4%2.49M after
Jul 15, 2022 (view filing)Jul 13-142 daysBancel StephaneChief Executive OfficerSSale−80.0K$166.63−$13.3M−1.5%5.41M after15 lots
Jul 15, 2022 (view filing)Jul 141 dayBancel StephaneChief Executive OfficerSSale−10.0K$169.31−$1.69M−0.1%6.80M after
Jul 15, 2022 (view filing)Jul 132 daysAndres JuanSee remarksSSale−2.00K$168.88−$337.8K−16.2%10.4K after
Jul 15, 2022 (view filing)Jul 132 daysAfeyan NoubarDirectorSSale−10.0K$168.88−$1.69M−0.4%2.50M afterDuplicate filing
Jul 15, 2022 (view filing)Jul 132 daysAfeyan NoubarDirectorSSale−10.0K$168.88−$1.69M−0.4%2.50M after
Jul 14, 2022 (view filing)Jul 12-132 daysHoge StephenPresidentSSale−10.0K$171.81−$1.72M−0.6%1.62M after2 lots
Jul 8, 2022 (view filing)Jul 6-72 daysBancel StephaneChief Executive OfficerSSale−80.0K$164.07−$13.1M−1.5%5.41M after11 lots
Jul 8, 2022 (view filing)Jul 71 dayBancel StephaneChief Executive OfficerSSale−10.0K$159.54−$1.60M−0.1%6.81M after
Jul 8, 2022 (view filing)Jul 62 daysAndres JuanSee remarksSSale−2.00K$154.85−$309.7K−16.2%10.4K after
Jul 8, 2022 (view filing)Jul 62 daysAfeyan NoubarDirectorSSale−10.0K$154.85−$1.55M−0.4%2.51M after
Jul 5, 2022 (view filing)Jul 14 daysAndres JuanSee remarksSSale−6.00K$150.00−$900.0K−36.7%10.4K after
Jul 1, 2022 (view filing)Jun 29-302 daysBancel StephaneChief Executive OfficerSSale−80.0K$142.84−$11.4M−1.5%5.41M after16 lots
Jul 1, 2022 (view filing)Jun 301 dayBancel StephaneChief Executive OfficerSSale−10.0K$143.40−$1.43M−0.1%6.82M after
Jul 1, 2022 (view filing)Jun 292 daysAfeyan NoubarDirectorSSale−10.0K$140.47−$1.40M−0.4%2.52M after
Jun 27, 2022 (view filing)Jun 23-244 daysHoge StephenPresidentSSale−10.0K$139.97−$1.40M−0.6%1.62M after2 lots
Jun 24, 2022 (view filing)Jun 22-232 daysBancel StephaneChief Executive OfficerSSale−80.0K$138.69−$11.1M−1.5%5.41M after14 lots
Jun 24, 2022 (view filing)Jun 231 dayBancel StephaneChief Executive OfficerSSale−10.0K$135.96−$1.36M−0.1%6.83M after
Jun 24, 2022 (view filing)Jun 222 daysAfeyan NoubarDirectorSSale−10.0K$127.69−$1.28M−0.4%2.53M after
Jun 17, 2022 (view filing)Jun 15-162 daysBancel StephaneChief Executive OfficerSSale−80.0K$124.00−$9.92M−1.5%5.41M after10 lots
Jun 17, 2022 (view filing)Jun 161 dayBancel StephaneChief Executive OfficerSSale−10.0K$124.29−$1.24M−0.1%6.84M after
Jun 14, 2022 (view filing)Jun 131 dayHoge StephenPresidentSSale−10.0K$123.00−$1.23M−0.6%1.62M after
Jun 10, 2022 (view filing)Jun 8-92 daysBancel StephaneChief Executive OfficerSSale−80.0K$143.51−$11.5M−1.5%5.41M after12 lots
Jun 10, 2022 (view filing)Jun 91 dayBancel StephaneChief Executive OfficerSSale−10.0K$148.07−$1.48M−0.1%6.85M after
Jun 10, 2022 (view filing)Jun 82 daysAndres JuanSee remarksSSale−10.0K$150.00−$1.50M−49.1%10.4K after
Jun 10, 2022 (view filing)Jun 82 daysAfeyan NoubarDirectorSSale−10.0K$147.47−$1.47M−0.4%2.54M after
Jun 9, 2022 (view filing)Jun 81 dayKlinger Shannon ThymeChief Legal OfficerSSale−1.26K$148.12−$187.4K−27.8%3.29K after
Jun 3, 2022 (view filing)Jun 1-22 daysBancel StephaneChief Executive OfficerSSale−80.0K$140.14−$11.2M−1.5%5.41M after15 lots
Jun 3, 2022 (view filing)Jun 21 dayBancel StephaneChief Executive OfficerSSale−10.0K$140.00−$1.40M−0.1%6.86M after
Jun 3, 2022 (view filing)Jun 12 daysAfeyan NoubarDirectorSSale−10.0K$146.31−$1.46M−0.4%2.55M after
Jun 1, 2022 (view filing)May 311 dayAndres JuanSee remarksSSale−749$145.40−$108.9K−6.7%10.4K after
Jun 1, 2022 (view filing)May 311 dayHoge StephenPresidentSSale−8.43K$145.02−$1.22M−0.5%1.62M after2 lots